Ronald Piervincenzi, USP, explains why drug supply resilience needs a system approach, from procurement benchmarks to regulatory capacity building.
Ronald T. Piervincenzi
Advertisement
CEO
United States Pharmacopeia (USP)
Articles by Ronald T. Piervincenzi
Ronald Piervincenzi, USP, explains why drug supply resilience needs a system approach, from procurement benchmarks to regulatory capacity building.
Ronald Piervincenzi, USP, urges drugmakers and purchasers to act on supply chain resilience to curb drug shortages and shape better policy.
Ronald Piervincenzi, USP, explains why manufacturers should act now and how benchmarking could reward reliable generic drug suppliers.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
FDA Rare Disease Framework Puts CMC Review in Scope
2
Rare Pediatric PRVs: Manufacturing Strategies for Expedited Approval, Part 1
3
Manufacturing Intelligence: What FDA's Real-World Use Case Database Means for CMC
4
PharmTech AI Pulse Check: AI Watermark Vulnerability
5